SCHEMBL9325286

SCHEMBL9325286

C(=NC1C2CCN(CC2)C1C(c1ccccc1)c1ccccc1)c1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 18/20 0.43
NPC1 O15118 1/20 0.39
MTOR P42345 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9325275 1.00 TACR1 (0.43) TACR1NPC1MTORRAB9A
SCHEMBL9325272 1.00 TACR1 (0.43) TACR1NPC1MTORRAB9A
SCHEMBL9325280 1.00 TACR1 (0.43) TACR1NPC1MTORRAB9A
SCHEMBL9322004 0.87 TACR1 (0.40) TACR1NPC1MTORRAB9A
SCHEMBL9321994 0.87 TACR1 (0.40) TACR1NPC1MTORRAB9A
SCHEMBL9321997 0.87 TACR1 (0.40) TACR1NPC1MTORRAB9A
SCHEMBL9322000 0.87 TACR1 (0.40) TACR1NPC1MTORRAB9A
SCHEMBL9324143 0.85 TACR1 (0.52) TACR1
SCHEMBL9325219 0.85 TACR1 (0.52) TACR1
SCHEMBL9322749 0.85 TACR1 (0.52) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0409931-B1 QUINUCLIDINE THERAPEUTIC AGENTS PFIZER (US) 1994-02-16 EP disclosed
US-5162339-A Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics PFIZER INC. (US) 1992-11-10 US disclosed
WO-1990005525-A1 QUINUCLIDINE DERIVATIVES AS SUBSTANCE P ANTAGONISTS PFIZER INC. (US) 1990-05-31 WO disclosed